1. Home
  2. UBCP vs ENTX Comparison

UBCP vs ENTX Comparison

Compare UBCP & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UBCP

United Bancorp Inc.

HOLD

Current Price

$14.00

Market Cap

78.4M

Sector

Finance

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.36

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBCP
ENTX
Founded
1902
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.4M
74.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
UBCP
ENTX
Price
$14.00
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
3.7K
266.9K
Earning Date
01-26-2026
11-14-2025
Dividend Yield
6.73%
N/A
EPS Growth
N/A
N/A
EPS
1.31
N/A
Revenue
$30,516,000.00
$124,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.59
N/A
P/E Ratio
$10.61
N/A
Revenue Growth
4.40
25.25
52 Week Low
$12.25
$1.36
52 Week High
$15.64
$3.22

Technical Indicators

Market Signals
Indicator
UBCP
ENTX
Relative Strength Index (RSI) 50.62 31.83
Support Level $13.85 $1.52
Resistance Level $14.15 $1.59
Average True Range (ATR) 0.31 0.13
MACD -0.00 -0.00
Stochastic Oscillator 42.34 9.79

Price Performance

Historical Comparison
UBCP
ENTX

About UBCP United Bancorp Inc.

United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: